Information, not a decision

Chronic myeloid leukaemia: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 12 Nov 2026

Open trials (190)

NCT03589729	Phase 2	Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	Recruiting
NCT07789574	Phase 2	Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations	Recruiting
NCT03263572	Phase 2	Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia	Recruiting
NCT07354074	Phase 2	Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP	Recruiting
NCT06523556	Phase 1/2	Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia	Recruiting
NCT04877522	Phase 4	Asciminib Roll-over Study	Recruiting
NCT07651878	Phase 1	Vididencel in CML-CP Patients With MRD	Recruiting
NCT07468916	Phase 2	Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia	Not yet recruiting
NCT06788509	Phase 1	A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring	By invitation only
NCT07914556	Phase 1	Phase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood Cancers	Recruiting
NCT07604233	Phase 1/2	Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML	Not yet recruiting
NCT06629584	Phase 2	Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia	Recruiting

178 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

No phase 3 trial in this list ended in the last 90 days.

Guidelines

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026

https://frontlightresearch.com/en/doctor/chronic-myeloid-leukemia/tumor-board